HealthEquity (HQY) revenue and earnings history
HealthEquity reported revenue of $1.31B for fiscal 2026 (year ended Jan 31, 2026), +9.5% on the year before, and net income of $215M.
Over 13 years, from fiscal 2013 to fiscal 2026, revenue grew at a compound rate of +29.4% a year.
Revenue and net income, 14 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Jan 31, 2026 | $1.31B+9.5% | $322M | $215M | $457M | $1.97M | $455M | $73.1M | $299M | — | $319M | $957M | 10-K |
| 2025ended Jan 31, 2025 |
The latest quarter, insider trades and fund moves: HealthEquity (HQY) on OQRO.
Common questions
What was HealthEquity's revenue in fiscal 2026?
$1.31B for the year ended Jan 31, 2026, as reported in its 10-K filed Mar 17, 2026. That is +9.5% on fiscal 2025 ($1.2B).
How fast has HealthEquity's revenue grown?
From $46.1M in fiscal 2013 to $1.31B in fiscal 2026: a compound annual growth rate of +29.4% over 13 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure HealthEquity tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.